These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36731507)

  • 1. The prevalence of diabetic peripheral neuropathy in youth with diabetes mellitus.
    Sophausvaporn P; Boonhong J; Sahakitrungruang T
    Ann Pediatr Endocrinol Metab; 2023 Mar; 28(1):20-25. PubMed ID: 36731507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-yr follow-up study for the detection of peripheral neuropathy in young patients with type 1 diabetes.
    Hajas G; Kissova V; Tirpakova A
    Pediatr Diabetes; 2016 Dec; 17(8):632-641. PubMed ID: 27028140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of Neuropathy-Related Disability and Associated Factors of Diabetic Peripheral Neuropathy in a Tertiary Healthcare Center: A Comparative Cross-Sectional Study.
    Francis D; Kotteeswaran K; Padinhare Veedu P
    Cureus; 2024 Mar; 16(3):e55568. PubMed ID: 38576639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes.
    Nelson D; Mah JK; Adams C; Hui S; Crawford S; Darwish H; Stephure D; Pacaud D
    Pediatr Diabetes; 2006 Dec; 7(6):305-10. PubMed ID: 17212597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence and Incidence of Diabetic Peripheral Neuropathy in Children and Adolescents With Type 1 Diabetes Mellitus: Results From a Five-Year Prospective Cohort Study.
    Walter-Höliner I; Barbarini DS; Lütschg J; Blassnig-Ezeh A; Zanier U; Saely CH; Simma B
    Pediatr Neurol; 2018 Mar; 80():51-60. PubMed ID: 29429781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard Clinical Screening Tests, Sural Radial Amplitude Ratio and F Wave Latency Compared to Conventional Nerve Conduction Studies in the Assessment of Sensorimotor Polyneuropathy in Patients with Type 2 Diabetes Mellitus.
    Ramanathan S; Thomas R; Chanu AR; Naik D; Jebasingh F; Sivadasan A; Thomas N
    Indian J Endocrinol Metab; 2021; 25(6):509-515. PubMed ID: 35355904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Semmes Weinstein 10 gm monofilament in diabetic peripheral neuropathy taking nerve conduction and autonomic function study as reference tests.
    Dube S; Hulke SM; Wakode SL; Khadanga S; Thakare AE; Bharshankar RN; Pakhare A
    J Family Med Prim Care; 2022 Oct; 11(10):6204-6208. PubMed ID: 36618173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: Diagnosis, pathogenesis, and associated genetic markers.
    Kallinikou D; Soldatou A; Tsentidis C; Louraki M; Kanaka-Gantenbein C; Kanavakis E; Karavanaki K
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3178. PubMed ID: 31083769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity of the Z-2 polymorphic variant in the aldose reductase gene promoter confers increased risk for neuropathy in children and adolescents with Type 1 diabetes.
    Kallinikou D; Tsentidis C; Kekou K; Katsalouli M; Louraki M; Kanaka-Gantenbein C; Kanavakis E; Karavanaki K
    Pediatr Diabetes; 2022 Feb; 23(1):104-114. PubMed ID: 34773353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
    Olaleye D; Perkins BA; Bril V
    Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of nephropathy in Indian children and youth with type 1 diabetes mellitus.
    Karguppikar M; Oza C; Shah N; Khadilkar V; Gondhalekar K; Khadilkar A
    J Pediatr Endocrinol Metab; 2022 May; 35(5):585-592. PubMed ID: 35304981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-specific quality of life in patients with diabetic neuropathy.
    Alghamdi M; Owolabi LF; Adamu B; Taura MG; Jibo A; Almansour M; Alaklabi SN; Alghamdi MA; Imam IA; Abdelrazak R; Rafaat A; Aliyu MH
    Saudi Med J; 2022 Apr; 43(4):408-417. PubMed ID: 35414620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Diabetic Peripheral Neuropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study.
    TODAY Study Group
    Diabetes Care; 2021 Oct; 45(5):1065-72. PubMed ID: 34716210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical Neuropathy in Children With Type I Diabetes Mellitus: Tertiary Care Centre Experience.
    Altuwaijri WA; Almutair AN; AlAlwan IA; Almahdi MJ; Almasoud SD
    Cureus; 2022 Aug; 14(8):e27765. PubMed ID: 35949448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening.
    Baraz S; Zarea K; Shahbazian HB; Latifi SM
    J Diabetes Metab Disord; 2014 Jan; 13(1):19. PubMed ID: 24472435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plantar pressure as a risk assessment tool for diabetic foot ulceration in egyptian patients with diabetes.
    Fawzy OA; Arafa AI; El Wakeel MA; Abdul Kareem SH
    Clin Med Insights Endocrinol Diabetes; 2014; 7():31-9. PubMed ID: 25520564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
    McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
    Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy.
    Fateh HR; Madani SP; Heshmat R; Larijani B
    J Diabetes Metab Disord; 2015; 15():8. PubMed ID: 27019831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.
    Herman WH; Pop-Busui R; Braffett BH; Martin CL; Cleary PA; Albers JW; Feldman EL;
    Diabet Med; 2012 Jul; 29(7):937-44. PubMed ID: 22417277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age as an independent factor for the development of neuropathy in diabetic patients.
    Popescu S; Timar B; Baderca F; Simu M; Diaconu L; Velea I; Timar R
    Clin Interv Aging; 2016; 11():313-8. PubMed ID: 27042031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.